| Date Filed | Type | Description |
| 08/16/2023 |
4
| Nolan Sean P. (CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Bought 444,444 shares
@ $0.9, valued at
$400k
|
|
| 05/18/2023 |
4
| Nolan Sean P. (Director) has filed a Form 4 on Ventas, Inc.|
Txns:
| Granted 3,835 shares
@ $45.63, valued at
$175k
|
|
| 01/04/2023 |
4
| Nolan Sean P. (CEO) has filed a Form 4 on Taysha Gene Therapies, Inc.|
Txns:
| Granted 1,106,131 options to buy
@ $2.26, valued at
$2.5M
|
|
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2021 |
3
| Nolan Sean P. (Director) has filed a Form 3 on Social Capital Suvretta Holdings Corp. II |
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/30/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/23/2020 |
3
| Nolan Sean P. (Director) has filed a Form 3 on Taysha Gene Therapies, Inc. |
| 05/20/2020 |
4
| Nolan Sean P. (Director) has filed a Form 4 on Ventas, Inc.|
Txns:
| Granted 5,424 shares
@ $0 |
|
| 05/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/15/2019 |
4
| Nolan Sean P. (Director) has filed a Form 4 on Neoleukin Therapeutics, Inc.|
Txns:
| Granted 22,000 options to buy
@ $2.82, valued at
$62k
|
|
| 07/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/26/2019 |
3
| Nolan Sean P. (Director) has filed a Form 3 on Ventas, Inc. |
| 05/15/2018 |
4
| Nolan Sean P. (President & CEO) has filed a Form 4 on AveXis, Inc.|
Txns:
| Disposed/sold 11,000 shares
@ $0
Disposed/sold 728,300 options to buy
@ $15.94, valued at
$11.6M
Disposed/sold 110,000 options to buy
@ $42.61, valued at
$4.7M
Disposed/sold 96,000 options to buy
@ $77.24, valued at
$7.4M
Disposed/sold 44,000 options to buy
@ $133.8, valued at
$5.9M
|
|
| 05/09/2018 |
4
| Nolan Sean P. (Director) has filed a Form 4 on AQUINOX PHARMACEUTICALS, INC|
Txns:
| Granted 15,000 options to buy
@ $13.1, valued at
$196.5k
|
|
| 03/27/2018 |
4
| Nolan Sean P. (President & CEO) has filed a Form 4 on AveXis, Inc.|
Txns:
| Granted 11,000 shares
@ $0
Granted 44,000 options to buy
@ $133.8, valued at
$5.9M
|
|
| 03/09/2018 |
4
| Nolan Sean P. (President & CEO) has filed a Form 4 on AveXis, Inc.|
Txns:
| Sold 400 shares
@ $126.65, valued at
$50.7k
Sold 700 shares
@ $127.65, valued at
$89.4k
Sold 2,400 shares
@ $128.65, valued at
$308.8k
Sold 4,800 shares
@ $129.66, valued at
$622.4k
Sold 600 shares
@ $130.78, valued at
$78.5k
Sold 1,100 shares
@ $131.86, valued at
$145k
Exercised 10,000 options to buy
@ $15.94, valued at
$159.4k
|
|
| 05/12/2017 |
4
| Nolan Sean P. (President & CEO) has filed a Form 4 on AveXis, Inc. |
| 05/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/22/2016 |
4
| Nolan Sean P. (President & CEO) has filed a Form 4 on AveXis, Inc.|
Txns:
| Granted 110,000 options to buy
@ $42.61, valued at
$4.7M
|
|
| 05/11/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/10/2016 |
3
| Nolan Sean P. (President & CEO) has filed a Form 3 on AveXis, Inc. |
| 06/03/2013 |
4
| Nolan Sean P. (Executive VP & CBO) has filed a Form 4 on INTERMUNE INC|
Txns:
| Granted 4,000 options to buy
@ $0
Granted 20,000 options to buy
@ $9.99, valued at
$199.8k
|
|
| 03/11/2013 |
4
| Nolan Sean P. (Executive VP & CBO) has filed a Form 4 on INTERMUNE INC|
Txns:
| Granted 75,200 shares
@ $0
Granted 75,200 shares
@ $0
Granted 188,000 options to buy
@ $9.29, valued at
$1.7M
Granted 188,000 options to buy
@ $9.29, valued at
$1.7M
|
|
| 02/20/2013 |
3
| Nolan Sean P. (Executive VP & CBO) has filed a Form 3 on INTERMUNE INC |